Together, these data illustrate that T cells infiltrating pediatric AML and B-ALL express increased but variable patterns of inhibitory checkpoints (particularly TIGIT, in the case of B-ALL, and LAG3, in the case of AML), and also show evidence of T cell dysfunction but not complete exhaustion. The gene discussed is LAG3; the disease is acute lymphoblastic leukemia.